A protest over a draft decision not to recommend a new cystic fibrosis drug is due later. Campaigners keen to see Kalydeco introduced across Wales are aiming to make their voices heard outside a meeting of the All Wales Medicines Strategy Group at the Angel Hotel in Abergavenny.
The group will look at the recommendation and decide whether to approve it or not. The drug - which is already available in England, Scotland and Northern Ireland - is the first licensed drug that treats the G551D mutation - the fundamental defect in those with cystic fibrosis.
More top news
Winds are expected to ease this evening and showers will become lighter and more isolated. A drier and brighter day tomorrow.
After nearly six weeks of campaigning the race for Number 10 has reached its final stages.
Polling stations across Wales will open at 7am on Thursday May 7th. Here is a guide on 'how to' and 'how not to' vote.